AWM
VRTX icon

AllSquare Wealth Management’s Vertex Pharmaceuticals VRTX Stock Holding History

AllSquare Wealth Management’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$10.2K Hold
26
– – 0.01% 384
2025
Q2 		$11.6K Hold
26
– – 0.01% 369
2025
Q1 		$12.6K Buy
+26
New +$12.1K 0.01% 359

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

AllSquare Wealth Management's VRTX Position: Q3 2025 in Review

AllSquare Wealth Management held its Vertex Pharmaceuticals (VRTX) position steady in Q3 2025 at 26 shares worth $10.2K. The position accounts for 0.01% of the portfolio, ranked #384.

AllSquare Wealth Management first reported a position in VRTX in Q1 2025 and has held it in 3 quarters since. The position peaked at $12.6K in Q1 2025. 1,519 funds tracked by Wall St. Rank hold VRTX as of Q3 2025.

  • AllSquare Wealth Management held 26 shares of Vertex Pharmaceuticals worth $10.2K as of Q3 2025.
  • AllSquare Wealth Management left its Vertex Pharmaceuticals share count unchanged in Q3 2025.
  • Vertex Pharmaceuticals made up 0.01% of AllSquare Wealth Management's portfolio in Q3 2025, its #384 holding.
  • AllSquare Wealth Management first reported a position in Vertex Pharmaceuticals in Q1 2025 and has held it in 3 quarters since.
  • AllSquare Wealth Management's Vertex Pharmaceuticals position peaked at $12.6K in Q1 2025.
  • 1,519 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2025.

Based on AllSquare Wealth Management's 13F filing for Q3 2025, filed 12 Jan 2026.